Navigation Links
Standard Dose of Blood Thinner May Not Be Best for All Patients
Date:11/6/2012

TUESDAY, Nov. 6 (HealthDay News) -- Seventy-five percent of patients taking the widely used blood thinners clopidogrel (Plavix) and prasugrel (Effient) are getting the incorrect dose and could be at risk for serious problems such as uncontrolled bleeding or blood clots, a new study contends.

Millions of Americans with coronary artery disease take the drugs to prevent blood clots that could cause a heart attack or stroke. Guidelines recommend that all patients take the same standardized dose, but that dose is not effective for all patients, according to researchers at the Intermountain Medical Center Heart Institute in Salt Lake City.

The researchers looked at more than 500 patients and found that half of patients taking Plavix were getting too little of the drug to most effectively prevent blood clots, while a quarter were getting too much. Only a quarter were receiving an appropriate dose.

Among patients taking Effient, half were taking too much of the drug, which could lead to dangerous bleeding. A quarter were taking too little of the drug and a quarter were taking the appropriate dose.

The researchers also concluded that indicators like age, gender, cholesterol levels and history of heart problems were not good predictors for how a patient would react to the blood thinners.

"There's a sweet spot, an appropriate range for each patient. But we found that not many people are falling into that range," cardiac researcher Dr. Brent Muhlestein said in an institute news release.

"We showed that by performing a simple blood test to see whether or not the blood is clotting properly, we can determine whether patients are getting an appropriate, individualized dose of the medications," he added. "The test is easy to perform, but not widely used."

The study was presented Tuesday at the American Heart Association annual meeting in Los Angeles. The data and conclusions should be viewed as preliminary until published in a peer-reviewed journal.

More information

The U.S. Agency for Healthcare Research and Quality has more about blood thinners.

-- Robert Preidt

SOURCE: Intermountain Medical Center Heart Institute, news release, Nov. 6, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New research suggests standardized booster seat laws could save lives of children
2. Settings standards for research into Rett syndrome
3. Standard chemotherapy provides higher survival rate than experimental in lung cancer patients
4. First validated method for analyzing flavanols and procyanidins in cocoa products could help scientists and the industry in standardized reporting
5. Gold standards of success defined for AF ablation
6. CRT consensus set to standardize and improve care for patients worldwide
7. New device to remove stroke-causing blood clots proves better than standard tool
8. Alcohol advertising standards violations most common in magazines with youthful audiences
9. Standard radiation therapy dose provides pain relief for painful heel spurs
10. New technology represents next-generation tool for detecting substandard and counterfeit medicines
11. Adding Vitamin B12 to Standard Drugs Might Help Fight Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Standard Dose of Blood Thinner May Not Be Best for All Patients
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia is a ... on long-term patient survival, reports a team of UPMC researchers in the largest ... the Journal of Thoracic and Cardiovascular Surgery, provide critical information that will hopefully ...
(Date:5/26/2016)... Hampshire (PRWEB) , ... May 26, 2016 , ... MadgeTech ... are designed, engineered, and manufactured in Warner, New Hampshire at the MadgeTech headquarters. With ... provide reliable monitoring solutions trusted by government agencies, including NASA. , In 2012, ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... Retinal Degeneration” for the Foundation Fighting Blindness, Long Island Chapter on June 4, ... the public. , Dr. Maisel, founder of Retina Group of New York ...
(Date:5/26/2016)... ... May 26, 2016 , ... In an effort to provide hair restoration information to the ... users and those who do not use the app. Dr. Mohebi, the founder of Parsa ... Dr. Mohebi Live . , Dr. Mohebi says, “The positive response to the Snapchat ...
(Date:5/26/2016)... Indiana (PRWEB) , ... May 26, 2016 , ... ... provider of healthcare supply chain solutions, today announced the organization has earned its ... meets international standards and is compliant with all rules and policies associated with ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... CORAL SPRINGS, Florida , May 25, 2016 /PRNewswire/ ... Marijuana Business Conference & Expo earlier this month, the ... undeniable. As revenues continue to climb into the billions, ... to the newly released 4th Edition State of Legal ... New Frontier, a cannabis-focused data-analysis firm, much of the ...
(Date:5/25/2016)... Texas , May 25, 2016 ... the issuance to it by the US Patent ... The company,s technology includes proprietary processes for electronic ... for health and wellness programs, HIPAA compliance and ... "Our technology ...
(Date:5/25/2016)... England , May 25, 2016 ... company employing the precision of circulating tumour DNA ... today announces the appointment of Professor Clive ... provide medical leadership across the clinical development programme, ... Inivata,s products help deliver significant improvements in clinical ...
Breaking Medicine Technology: